What is Antibody Solutions?
Antibody Solutions is a specialized provider of fit-for-purpose antibodies, dedicated to advancing diagnostics and therapeutics for biopharmaceutical companies. Leveraging over three decades of expertise, the company offers comprehensive services including antibody discovery, assay development, and antigen development, while ensuring clients maintain full intellectual property rights. Its reputation is built on rigorous project management and a flexible fee-for-service model, making it a trusted partner for 100% of the top 10 research pharmaceutical companies and over 700 biopharma clients, evidenced by a high client retention rate.
How much funding has Antibody Solutions raised?
Antibody Solutions has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Antibody Solutions?
The recent strategic investment signals a pivotal moment for Antibody Solutions, likely indicating a move towards scaling operations, expanding service offerings, or accelerating research and development initiatives. Given the large-scale late-stage funding context, the company is poised to further solidify its market leadership and potentially explore new therapeutic areas or diagnostic applications. This capital infusion is expected to fuel innovation and enhance its capacity to support the complex needs of the global biopharmaceutical industry, reinforcing its role as a key enabler of drug discovery and development.
See full Antibody Solutions company page
